Misclassification of cause of death in cancer patients

July 16, 2002

The overall cancer mortality rate could increase by about 1% if all deaths within 1 month of cancer-related surgery were correctly attributed to the underlying cancer rather than the surgical procedure, suggests new research appearing in the July 17 issue of the Journal of the National Cancer Institute.

In making judgments about the progress against cancer, deaths from treatment and diagnosis must also be accounted for, conclude study authors H. Gilbert Welch, M.D., and William C. Black, M.D., of Dartmouth Medical School.

The calculation of cancer mortality depends on the accurate determination of the underlying cause of death. Welch and Black argue that cancer mortality should include deaths from treatment for cancer as well as deaths from the disease. They note, however, that clear guidelines for classifying treatment-related deaths in cancer do not exist.

As a rule, researchers consider deaths within 30 days of a surgical procedure to be treatment-related when calculating mortality from the underlying disease.

To determine if this rule is being applied uniformly to cancer patients, Welch and Black used national cancer registry data to find out the reported cause of death in patients who, between 1994 and 1998, died within 1 month of cancer-related surgery to remove a solid tumor. Among the 4,135 deaths within 1 month of diagnosis and cancer-related surgery, 41% were attributed to a cause other than the cancer. The proportion of cases not attributed to cancer ranged from 13% for cervical cancer to 81% for laryngeal cancer. The authors note that there is a trend toward increasing misclassification among those cancers, such as breast and prostate, in which early detection has increased substantially.

If all deaths within 1 month of cancer-directed surgery were attributed to cancer, cancer mortality would rise by about 1% over current estimates in national trends, they authors say. They note that the proportion of deaths not attributed to cancer was highest during the period immediately following surgery. If all deaths in the year following cancer-directed surgery were attributed to cancer, then, according to the authors, the reported cancer mortality would increase from 2% to 4%.

The authors conclude that some deaths resulting from cancer-related surgery are not being properly attributed to cancer. "Although the estimated effect of this misclassification on overall cancer mortality is modest, it may be indicative of more widespread confusion about how to code treatment-related deaths of patients with cancer," they write.

The authors propose developing some rules under which all deaths within 1 month of surgery, radiation therapy, or chemotherapy are attributed to the cancer for which the treatments were initiated.

In an accompanying editorial, Colin B. Begg, Ph.D., and Deborah Schrag, M.D., of the Memorial Sloan-Kettering Cancer Center in New York, caution that the proposed changes in classifying cancer-related deaths may introduce inaccuracies. They note that deaths do occur suddenly and unpredictably, especially among older patients. Moreover, many deaths have multiple causes, and attributing death to one disease does not recognize the complexity of the issue.

Begg and Schrag conclude that "in view of the fact that the science of nosology (the determination of cause of death) is unlikely to ever be perfected, cause-specific mortality estimates must always be interpreted with caution in the context of related statistics on disease incidence and relative survival."
-end-
Contact: Hali Wickner, Dartmouth Medical School, (603) 650-1492, fax (603) 650-1730; DMS.communications@dartmouth.edu

Editorial: Christine Hickey, Memorial Sloan-Kettering Cancer Center, (212) 639-3573, fax (212) 639-3576, publicaffairs@mskcc.org.

Welch G, Black C. Are deaths within 1 month of cancer-directed surgery attributed to cancer? J Natl Cancer Inst 2002;94:1066-70.

Begg C, Schrag D. Attribution of deaths following cancer surgery. J Natl Cancer Inst 2002;94:1044-5.

Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.